Method for Improved Intraoperative Blood Loss Estimates (EBL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by University of Utah.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Annette Macintyre, University of Utah
ClinicalTrials.gov Identifier:
NCT01634828
First received: July 2, 2012
Last updated: July 5, 2012
Last verified: July 2012
  Purpose

The purpose of this study is to develop a mathematical algorithm which the investigators plan to use to more accurately estimate intraoperative blood loss.


Condition
Improved Intraoperative Blood Loss Estimates

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Method for Improved Intraoperative Blood Loss Estimates

Resource links provided by NLM:


Further study details as provided by University of Utah:

Estimated Enrollment: 50
Study Start Date: July 2012
Groups/Cohorts
Minimal blood loss patients
Moderate to heavy blood loss patients

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Elective surgical patients

Criteria

Inclusion Criteria:

All elective surgical patients

Exclusion Criteria:

  1. Age < 18
  2. Pregnant women
  3. Prisoners
  4. Lack of informed consent
  5. Attending Physician feels enrollment could interfere with optimal patient care
  6. Patients who did not have a preoperative hemoglobin measured as part of their preoperative work-up
  7. Patients whose preoperative hemoglobin fraction is abnormal.
  8. Patients who will likely require an intraoperative blood transfusion.
  9. Patients for whom the intraoperative use of the Cell Saver is anticipated.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01634828

Locations
United States, Utah
University of Utah Recruiting
Salt lake City, Utah, United States, 84132
Contact: Annette MacIntyre, MD    801-205-1028    annette.macintyre@hsc.utah.edu   
Sponsors and Collaborators
University of Utah
  More Information

No publications provided

Responsible Party: Annette Macintyre, Principle Investigator, University of Utah
ClinicalTrials.gov Identifier: NCT01634828     History of Changes
Other Study ID Numbers: FP00002762, 56181
Study First Received: July 2, 2012
Last Updated: July 5, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hemorrhage
Pathologic Processes

ClinicalTrials.gov processed this record on September 30, 2014